The average calorie count in a meal when dining out topped out at 977 kcal in a study of 27 restaurant chains across Great Britain, while only 9% met public health recommendations for energy content. (The BMJ)
Roughly 4% of cancers across the globe may be directly attributed to overweight and obesity. (CA: A Cancer Journal for Clinicians)
The gut microbiome may alter the effectiveness of oral diabetes medications. (ScienceDaily)
This week, Pfenex submitted a new drug application to the FDA for their osteoporosis treatment PF708 as a “therapeutic equivalent” — a cross between a generic drug and biosimilar — to teriparatide (Forteo).
The exercise-released hormone irisin showed promise in a lab study as an osteoporosis treatment. (Cell)
A virtual reality therapist to help women suffering with hot flashes associated with menopause is slated to hit the market early next year, said maker VRHealth.
In other menopause symptom-treatment news, the phase IIb SWITCH-1 trial is now underway to assess the investigational non-hormonal agent NT-814, announced KaNDy Therapeutics.
Human growth hormones from the pituitary glands of cadavers were found to plant the “seed” of Alzheimer’s disease amyloid proteins in mice. (Nature)